EcoDrugPlus

Glycogen Synthase Kinase 3 Beta, Genome Duplicate A

Ensembl ID : ENSONIG00000014396
Gene Symbol: GSK3BA
1 Cross references
222 Possible Orthologues:

Gonadotropin Receptor I

Ensembl ID : ENSONIG00000035442
Gene Symbol: GTH-RI
2 Cross references
200 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSONIG00000002118
Gene Symbol: GHRHR
4 Cross references
191 Possible Orthologues:

Growth Hormone Secretagogue Receptor Type 1

Ensembl ID : ENSONIG00000030026
Gene Symbol: LOC100699280
3 Cross references
212 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSONIG00000017599
Gene Symbol: GUCY1A1
4 Cross references
201 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSONIG00000005074
Gene Symbol: GUCY1A2
4 Cross references
202 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSONIG00000017604
Gene Symbol: GUCY1B1
1 Cross references
210 Possible Orthologues:

Heat Shock Protein 90, Alpha (Cytosolic), Class B Member 1

Ensembl ID : ENSONIG00000005936
Gene Symbol: HSP90AB1
1 Cross references
339 Possible Orthologues:

Heat Shock Protein Hsp 90-Alpha

Ensembl ID : ENSONIG00000000819
Gene Symbol: LOC100701982
3 Cross references
330 Possible Orthologues:

High Mobility Group Protein B1

Ensembl ID : ENSONIG00000005505
Gene Symbol: LOC100702822
3 Cross references
509 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSONIG00000020434
Gene Symbol: HRH1
4 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSONIG00000001869
Gene Symbol: HRH2
4 Cross references
182 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).